STUDY SAYS DRUG FIRMS WILL BE HURT BY RECENT TAX, MEDICAID LEGISLATION

STUDY SAYS DRUG FIRMS WILL BE HURT BY RECENT TAX, MEDICAID LEGISLATION

Pharmaceutical companies' costs will rise an estimated $14.5 billion during the next five years beca